← Open Payments lookup

KATHLEEN ENNIS: Open Payments

NPI 1750417358 · COS COB, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,148 in 90 payments from 11 companies in 2025. Trend: 2023 $3,565 · 2024 $2,570 · 2025 $3,148

Food & beverage: $3,148
CompanyPaymentsAmount
ABBVIE INC.23$797
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$701
Otsuka America Pharmaceutical, Inc.14$572
Alkermes, Inc.8$239
E.R. Squibb & Sons, L.L.C.14$239
Lundbeck LLC8$219
Teva Pharmaceuticals USA, Inc.2$133
Takeda Pharmaceuticals U.S.A., Inc.1$125
Janssen Pharmaceuticals, Inc1$84
Vanda Pharmaceuticals Inc.1$20

Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, ABILIFY ASIMTUFII, ENTYVIO, ABILIFY MAINTENA, LYBALVI.

Industry payments across CT — which companies pay providers there.